{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:40Z","timestamp":1792788040161,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Disease Control and Prevention Administration"},{"name":"National Natural Science Foundation of China","award":["82373645"],"award-info":[{"award-number":["82373645"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanghai Talent Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-05071-9","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T03:21:57Z","timestamp":1784517717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of albendazole versus praziquantel in the treatment of Clonorchis sinensis infection: an infection intensity-stratified, open-label, phase 2, randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Men-Bao","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Guang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"5071_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0140-6736(15)60313-0","volume":"387","author":"MB Qian","year":"2016","unstructured":"Qian MB, Utzinger J, Keiser J, Zhou XN, Clonorchiasis. Lancet. 2016;387:800\u201310.","journal-title":"Lancet"},{"key":"5071_CR2","doi-asserted-by":"publisher","first-page":"e0000923","DOI":"10.1128\/cmr.00009-23","volume":"37","author":"MB Qian","year":"2024","unstructured":"Qian MB, Keiser J, Utzinger J, Zhou XN. Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control. Clin Microbiol Rev. 2024;37:e0000923.","journal-title":"Clin Microbiol Rev"},{"key":"5071_CR3","doi-asserted-by":"publisher","first-page":"e42471","DOI":"10.1371\/journal.pone.0042471","volume":"7","author":"T Qiao","year":"2012","unstructured":"Qiao T, Ma RH, Luo XB, Luo ZL, Zheng PM. Cholecystolithiasis is associated with Clonorchis sinensis infection. PLoS ONE. 2012;7:e42471.","journal-title":"PLoS ONE"},{"key":"5071_CR4","doi-asserted-by":"publisher","first-page":"e0009116","DOI":"10.1371\/journal.pntd.0009116","volume":"15","author":"MB Qian","year":"2021","unstructured":"Qian MB, Li HM, Jiang ZH, Yang YC, Lu MF, Wei K, et al. Severe hepatobiliary morbidity is associated with Clonorchis sinensis infection: the evidence from a cross-sectional community study. PLoS Negl Trop Dis. 2021;15:e0009116.","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens\u2013Part B: biological agents. Lancet Oncol. 2009;10:321\u20132.","journal-title":"Lancet Oncol"},{"key":"5071_CR6","doi-asserted-by":"publisher","first-page":"106528","DOI":"10.1016\/j.jinf.2025.106528","volume":"91","author":"MB Qian","year":"2025","unstructured":"Qian MB, Huang JL, Wang L, Zhou CH, Zhu TJ, Zhu HH, et al. Clonorchiasis in China: geospatial modeling of the population infected and at risk, based on national surveillance. J Infect. 2025;91:106528.","journal-title":"J Infect"},{"key":"5071_CR7","first-page":"100697","volume":"33","author":"HY Xiao","year":"2023","unstructured":"Xiao HY, Chai JY, Fang YY, Lai YS. The spatial-temporal risk profiling of Clonorchis sinensis infection over 50 years implies the effectiveness of control programs in South Korea: a geostatistical modeling study. Lancet Reg Health West Pac. 2023;33:100697.","journal-title":"Lancet Reg Health West Pac"},{"key":"5071_CR8","doi-asserted-by":"publisher","first-page":"e0008483","DOI":"10.1371\/journal.pntd.0008483","volume":"14","author":"TTB Nguyen","year":"2020","unstructured":"Nguyen TTB, Dermauw V, Dahma H, Bui DT, Le TTH, Phi NTT, et al. Prevalence and risk factors associated with Clonorchis sinensis infections in rural communities in northern Vietnam. PLoS Negl Trop Dis. 2020;14:e0008483.","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR9","unstructured":"WHO. Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021\u20132030. 2020."},{"key":"5071_CR10","unstructured":"WHO. Neglected tropical diseases: Clonorchiasis. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/neglected-tropical-diseases-clonorchiasis (accessed on 23 June, 2025)."},{"key":"5071_CR11","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1371\/journal.pntd.0000601","volume":"4","author":"MH Choi","year":"2010","unstructured":"Choi MH, Park SK, Li Z, Ji Z, Yu G, Feng Z, et al. Effect of control strategies on prevalence, incidence and re-infection of clonorchiasis in endemic areas of China. PLoS Negl Trop Dis. 2010;4:e601.","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3347\/kjp.1998.36.4.249","volume":"36","author":"ST Hong","year":"1998","unstructured":"Hong ST, Yoon K, Lee M, Seo M, Choi MH, Sim JS, et al. Control of clonorchiasis by repeated praziquantel treatment and low diagnostic efficacy of sonography. Korean J Parasitol. 1998;36:249\u201354.","journal-title":"Korean J Parasitol"},{"key":"5071_CR13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1046\/j.1365-3156.1999.00499.x","volume":"4","author":"N Tinga","year":"1999","unstructured":"Tinga N, De N, Vien HV, Chau L, Toan ND, Kager PA, et al. Little effect of praziquantel or artemisinin on clonorchiasis in Northern Vietnam. A pilot study. Trop Med Int Health. 1999;4:814\u20138.","journal-title":"Trop Med Int Health"},{"key":"5071_CR14","doi-asserted-by":"publisher","first-page":"e3046","DOI":"10.1371\/journal.pntd.0003046","volume":"8","author":"LL Xu","year":"2014","unstructured":"Xu LL, Jiang B, Duan JH, Zhuang SF, Liu YC, Zhu SQ, et al. Efficacy and safety of praziquantel, tribendimidine and mebendazole in patients with co-infection of Clonorchis sinensis and other helminths. PLoS Negl Trop Dis. 2014;8:e3046.","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR15","first-page":"27","volume":"104","author":"YH Liu","year":"1991","unstructured":"Liu YH, Wang XG, Gao P, Qian MX. Experimental and clinical trial of albendazole in the treatment of clonorchiasis sinensis. Chin Med J (Engl). 1991;104:27\u201331.","journal-title":"Chin Med J (Engl)"},{"key":"5071_CR16","unstructured":"Centers for Disease Control and Prevention. Clinical Overview of Clonorchis. https:\/\/www.cdc.gov\/liver-flukes\/hcp\/clinical-overview-clonorchis\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/parasites\/clonorchis\/health_professionals\/index.html (accessed 23 June, 2025)."},{"key":"5071_CR17","first-page":"219","volume":"30","author":"Z Ying-Yan","year":"2018","unstructured":"Ying-Yan Z, Ting-Jun X, Man W, Yue-Yi F, Le L. Prevalence of Clonorchis sinensis infection and effect of albendazole treatment among residents in two communities of Zhongshan City. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2018;30:219\u201321.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"key":"5071_CR18","doi-asserted-by":"publisher","first-page":"105246","DOI":"10.1016\/j.actatropica.2019.105246","volume":"202","author":"ZH Deng","year":"2020","unstructured":"Deng ZH, Fang YY, Zhang QM, Mao Q, Pei FQ, Liu MR. The control of clonorchiasis in Guangdong province, southern China. Acta Trop. 2020;202:105246.","journal-title":"Acta Trop"},{"key":"5071_CR19","first-page":"1291","volume":"6","author":"Q Feng","year":"2006","unstructured":"Feng Q, Luo L, Xia SL, Zhang RH, Wu HD, Fan MG, et al. Compare the efficacy of two antiparasitic drugs against Clonorchiasis. J Trop Med. 2006;6:1291\u20132.","journal-title":"J Trop Med"},{"key":"5071_CR20","doi-asserted-by":"publisher","first-page":"e616","DOI":"10.1016\/S2666-5247(22)00026-X","volume":"3","author":"MB Qian","year":"2022","unstructured":"Qian MB, Patel C, Palmeirim MS, Wang X, Schindler C, Utzinger J, et al. Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis. Lancet Microbe. 2022;3:e616\u201324.","journal-title":"Lancet Microbe"},{"key":"5071_CR21","unstructured":"Zhu YY. Compliance and determinants of mass chemotherapy for clonorchiasis in Binyang county, Guangxi. Master thesis. Chinese Center for Disease Control and Prevention. 2025."},{"key":"5071_CR22","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1093\/cid\/cis1011","volume":"56","author":"MB Qian","year":"2013","unstructured":"Qian MB, Yap P, Yang YC, Liang H, Jiang ZH, Li W, et al. Efficacy and safety of tribendimidine against Clonorchis sinensis. Clin Infect Dis. 2013;56:e76\u201382.","journal-title":"Clin Infect Dis"},{"key":"5071_CR23","first-page":"397","volume":"14","author":"N Katz","year":"1972","unstructured":"Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14:397\u2013400.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"5071_CR24","doi-asserted-by":"publisher","first-page":"e2975","DOI":"10.1371\/journal.pntd.0002975","volume":"8","author":"J Keiser","year":"2014","unstructured":"Keiser J, Silue KD, Adiossan LK, N\u2019Guessan NA, Monsan N, Utzinger J, et al. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial. PLoS Negl Trop Dis. 2014;8:e2975.","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR25","doi-asserted-by":"publisher","first-page":"e0005008","DOI":"10.1371\/journal.pntd.0005008","volume":"10","author":"B Barda","year":"2016","unstructured":"Barda B, Coulibaly JT, Puchkov M, Huwyler J, Hattendorf J, Keiser J. Efficacy and safety of moxidectin, synriam, synriam-praziquantel versus praziquantel against Schistosoma haematobium and S. mansoni infections: a randomized, exploratory phase 2 trial. PLoS Negl Trop Dis. 2016;10:e0005008.","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR26","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa2212825","volume":"388","author":"EC Mrimi","year":"2023","unstructured":"Mrimi EC, Welsche S, Ali SM, Hattendorf J, Keiser J. Emodepside for Trichuris trichiura and hookworm infection. N Engl J Med. 2023;388:1863\u201375.","journal-title":"N Engl J Med"},{"key":"5071_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13071-018-2670-6","volume":"11","author":"SH Farrell","year":"2018","unstructured":"Farrell SH, Anderson RM. Helminth lifespan interacts with non-compliance in reducing the effectiveness of anthelmintic treatment. Parasit Vectors. 2018;11:66.","journal-title":"Parasit Vectors"},{"key":"5071_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13071-017-2206-5","volume":"10","author":"SH Farrell","year":"2017","unstructured":"Farrell SH, Truscott JE, Anderson RM. The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission. Parasit Vectors. 2017;10:291.","journal-title":"Parasit Vectors"},{"key":"5071_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1756-3305-6-314","volume":"6","author":"MB Qian","year":"2013","unstructured":"Qian MB, Yap P, Yang YC, Liang H, Jiang ZH, Li W, et al. Accuracy of the Kato-Katz method and formalin-ether concentration technique for the diagnosis of Clonorchis sinensis, and implication for assessing drug efficacy. Parasit Vectors. 2013;6:314.","journal-title":"Parasit Vectors"},{"key":"5071_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13071-019-3594-5","volume":"12","author":"MB Qian","year":"2019","unstructured":"Qian MB, Zhuang SF, Zhu SQ, Deng XM, Li ZX, Zhou XN. Improving diagnostic performance of the Kato-Katz method for Clonorchis sinensis infection through multiple samples. Parasit Vectors. 2019;12:336.","journal-title":"Parasit Vectors"},{"key":"5071_CR31","doi-asserted-by":"publisher","first-page":"e1339","DOI":"10.1371\/journal.pntd.0001339","volume":"5","author":"JH Kim","year":"2011","unstructured":"Kim JH, Choi MH, Bae YM, Oh JK, Lim MK, Hong ST. Correlation between discharged worms and fecal egg counts in human clonorchiasis. PLoS Negl Trop Dis. 2011;5:e1339.","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR32","doi-asserted-by":"publisher","first-page":"107664","DOI":"10.1016\/j.actatropica.2025.107664","volume":"267","author":"YY Zhu","year":"2025","unstructured":"Zhu YY, Zhao JG, Zhao LY, Zhou CH, Meng J, Jiang ZH, et al. Determinants of Clonorchis sinensis infection and subsequent treatment: a qualitative study in Guangxi, China. Acta Trop. 2025;267:107664.","journal-title":"Acta Trop"},{"key":"5071_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13071-016-1311-1","volume":"9","author":"KV Shuford","year":"2016","unstructured":"Shuford KV, Turner HC, Anderson RM. Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review. Parasit Vectors. 2016;9:29.","journal-title":"Parasit Vectors"},{"key":"5071_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.2174\/0115748863310251240818091856","volume":"20","author":"B Sheoran","year":"2025","unstructured":"Sheoran B, Deb T, Misra S, Tuteja M, Vohra A, Beniwal R. Safety profile of mass administration of albendazole among school children (6\u201319 years): A prospective active surveillance study. Curr Drug Saf. 2025;20:334\u201340.","journal-title":"Curr Drug Saf"},{"key":"5071_CR35","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S1473-3099(24)00669-8","volume":"25","author":"A Krolewiecki","year":"2025","unstructured":"Krolewiecki A, Kepha S, Fleitas PE, van Lieshout L, Gelaye W, Messa A Jr., et al. Albendazole-ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2\/3 trial. Lancet Infect Dis. 2025;25:548\u201359.","journal-title":"Lancet Infect Dis"},{"key":"5071_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4269\/ajtmh.2007.76.603","volume":"76","author":"C Shen","year":"2007","unstructured":"Shen C, Choi MH, Bae YM, Yu G, Wang S, Hong ST. A case of anaphylactic reaction to praziquantel treatment. Am J Trop Med Hyg. 2007;76:603\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"5071_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3347\/kjp.2011.49.3.273","volume":"49","author":"JM Lee","year":"2011","unstructured":"Lee JM, Lim HS, Hong ST. Hypersensitive reaction to praziquantel in a clonorchiasis patient. Korean J Parasitol. 2011;49:273\u20135.","journal-title":"Korean J Parasitol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05071-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:58:47Z","timestamp":1792061927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05071-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5071"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05071-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Review Committee of National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research) (ref: 2024-009). This trial was registered with\n                      \n                      on 27 February 2025, number ISRCTN46268871 (\n                      \n                      ). The study was conducted in accordance with the Declaration of Helsinki. Written informed consents were obtained from all participants. After the study, the participants who remained positive after treatment, or who were positive but excluded due to exclusionary criteria (except for pregnant women or the individuals with other contraindications) were provided with praziquantel (25\u00a0mg\/kg 3 times daily for 1\u00a0day) free.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"562"}}